Enzalutamide/Sandoz Sandoz

Enzalutamide/Sandoz is an oral medication used to treat certain types of cancer. This prescription drug is manufactured by Sandoz Pharmaceuticals D.D. and is available in the EU market.

Enzalutamide/Sandoz is primarily used in the treatment of prostate cancer. It works by blocking the effects of androgens in the body, which can help slow the growth of cancer cells. This medication is often prescribed for advanced or metastatic prostate cancer that has spread to other parts of the body. Patients should consult their healthcare provider to understand the specific uses of Enzalutamide/Sandoz for their condition.

Common effects of Enzalutamide/Sandoz may include fatigue, hot flashes, and joint pain. Some users might experience nausea, diarrhea, or a decrease in appetite. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects. Patients should report any persistent or severe side effects to their healthcare provider.

Enzalutamide/Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any other medications they are taking to avoid potential interactions. Pregnant women and individuals with certain medical conditions should exercise caution and consult their healthcare provider before using this medication.

Enzalutamide/Sandoz may interact with other medications, including those metabolized by the liver. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the efficacy of Enzalutamide/Sandoz. Always consult your healthcare provider for personalized advice on managing potential interactions.